Hydreight Technologies Inc. (NURS) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone. Thank you so much for joining us. This is Hydrate Technologies Q2 investor webinar. We're going to go over the earnings today that were just released. So we'll just give it a few moments while we let everyone join as I see people still joining in the weight room. If you do have any questions, please don't hesitate to put them in that Q&A section. And we are going to be keeping this webinar to that 30 minutes. So Yeah, we're going to get through it pretty fast. But if you do have additional questions that we don't get to, please send them to our investor relations email at ir.hydrate.com. I'll also put that in the chat section for you. And just a reminder that we will be going over Just a reminder to take a look at our forward-looking statement as we will like to remind everyone that today's presentation will include forward-looking statements. The statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties. that could cause actual results to differ materially from those projected. So forward-looking statements may include but are not limited to statements about our growth strategies, product development, financial performance, regulatory outlook, and market opportunities. So we do not undertake any objection to update these statements except as required by applicable securities law. So for a full discussion of risk factors and uncertainties, please refer to our filings that are available on CDAR+. under Hydric Technologies there. And I will pass it off to Shane for you, our CEO, Shane Madden. Thank you, Abby. Hi, everybody. As the great Conor McGregor once said, say what you're going to do and go out and do it. So that's how I would describe 2025 so far, especially Q2. Obviously, we hav...